Advertisement
Australia markets open in 2 minutes
  • ALL ORDS

    7,862.30
    -147.10 (-1.84%)
     
  • AUD/USD

    0.6413
    +0.0009 (+0.15%)
     
  • ASX 200

    7,612.50
    -140.00 (-1.81%)
     
  • OIL

    85.39
    +0.03 (+0.04%)
     
  • GOLD

    2,399.80
    -8.00 (-0.33%)
     
  • Bitcoin AUD

    99,345.71
    +447.59 (+0.45%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Better Buy: CRISPR Therapeutics vs. Bluebird Bio

Better Buy: CRISPR Therapeutics vs. Bluebird Bio

Gene editing refers to techniques that allow researchers to modify the DNA of various organisms. Given that it offers the potential to help discover innovative therapies, it isn't surprising that more and more drugmakers are turning to the technology. Two prominent biotechs that focus on gene editing are CRISPR Therapeutics (NASDAQ: CRSP) and Bluebird Bio (NASDAQ: BLUE).